A previous report in this journal has suggested that germline deletions in
the proline-alanine-rich (PAPA-repeat) region of P57 (KIP2) are associated
with increased risk of a variety of cancers, including breast cancer. We ha
ve analyzed the association of P57 PAPA-repeat deletion polymorphisms and b
reast cancer risk as part of a population-based case-control study of breas
t cancer. We have not observed an association between the presence of one o
r two copies of deletion polymorphisms in P57 and breast cancer risk (adjus
ted odds ratio: 1.1, 95% confidence interval: 0.6-2.0), Further investigati
on is necessary to determine the functional significance of P57 deletion po
lymorphisms and their potential relationship with disease.